These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25905781)
61. A shared N-terminal hydrophobic tail for the formation of nanoparticulates. Zhang X; Wang K; Lin Q; Zheng M; Li Q; Li T; Hong Q; Zheng Q; Yu H; Gu Y; Li S; Xia N Nanomedicine (Lond); 2016 Sep; 11(17):2289-303. PubMed ID: 27499052 [TBL] [Abstract][Full Text] [Related]
62. The possible regions to design Human Papilloma Viruses vaccine in Iranian L1 protein. Dehghani B; Hasanshahi Z; Hashempour T; Motamedifar M Biologia (Bratisl); 2020; 75(5):749-759. PubMed ID: 32435064 [TBL] [Abstract][Full Text] [Related]
63. Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco. El-Aliani A; Alaoui MAE; Chaoui I; Ennaji MM; Attaleb M; Mzibri ME Bioinformation; 2017; 13(8):241-248. PubMed ID: 28959092 [TBL] [Abstract][Full Text] [Related]
64. Evaluation of serum antibody response to a newly identified B-cell epitope in the minor nucleocapsid protein L2 of human papillomavirus type 16. Lehtinen M; Niemelä J; Dillner J; Parkkonen P; Nummi T; Liski E; Nieminen P; Reunala T; Paavonen J Clin Diagn Virol; 1993 Aug; 1(3):153-65. PubMed ID: 15566729 [TBL] [Abstract][Full Text] [Related]
65. HPV Vaccination for Boys. Donoghue S Am J Nurs; 2016 Nov; 116(11):12. PubMed ID: 27787302 [No Abstract] [Full Text] [Related]
66. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490 [TBL] [Abstract][Full Text] [Related]
67. Next generation prophylactic human papillomavirus vaccines. Schiller JT; Müller M Lancet Oncol; 2015 May; 16(5):e217-25. PubMed ID: 25943066 [TBL] [Abstract][Full Text] [Related]
68. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies. Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404 [TBL] [Abstract][Full Text] [Related]
69. Phase II studies to select the formulation of a multivalent HPV L1 virus-like particle (VLP) vaccine. Luxembourg A; Brown D; Bouchard C; Giuliano AR; Iversen OE; Joura EA; Penny ME; Restrepo JA; Romaguera J; Maansson R; Moeller E; Ritter M; Chen J Hum Vaccin Immunother; 2015; 11(6):1313-22. PubMed ID: 25912208 [TBL] [Abstract][Full Text] [Related]
70. Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine. Seitz H; Ribeiro-Müller L; Canali E; Bolchi A; Tommasino M; Ottonello S; Müller M Cancer Prev Res (Phila); 2015 Oct; 8(10):932-41. PubMed ID: 26170394 [TBL] [Abstract][Full Text] [Related]
71. Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer. Milutin Gašperov N; Sabol I; Planinić P; Grubišić G; Fistonić I; Ćorušić A; Grce M PLoS One; 2015; 10(6):e0129452. PubMed ID: 26057381 [TBL] [Abstract][Full Text] [Related]
72. Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype. Bissett SL; Godi A; Fleury MJ; Touze A; Cocuzza C; Beddows S J Virol; 2015 Aug; 89(15):7748-57. PubMed ID: 25995264 [TBL] [Abstract][Full Text] [Related]
73. Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes. Jagu S; Karanam B; Wang JW; Zayed H; Weghofer M; Brendle SA; Balogh KK; Tossi KP; Roden RBS; Christensen ND Vaccine; 2015 Oct; 33(42):5553-5563. PubMed ID: 26382603 [TBL] [Abstract][Full Text] [Related]
74. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach. Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA Virol J; 2015 Sep; 12():140. PubMed ID: 26362430 [TBL] [Abstract][Full Text] [Related]
75. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls. Vesikari T; Brodszki N; van Damme P; Diez-Domingo J; Icardi G; Petersen LK; Tran C; Thomas S; Luxembourg A; Baudin M Pediatr Infect Dis J; 2015 Sep; 34(9):992-8. PubMed ID: 26090572 [TBL] [Abstract][Full Text] [Related]
76. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study. Frimer M; Sun C; McAndrew T; Smith B; Harari A; Chen Z; Mirabello L; Wentzensen N; Goldberg GL; Rodriguez AC; Schiffman M; Burk RD Gynecol Oncol; 2015 Jul; 138(1):94-100. PubMed ID: 26001326 [TBL] [Abstract][Full Text] [Related]
77. Sites of disruption within E1 and E2 genes of HPV16 and association with cervical dysplasia. Tsakogiannis D; Gortsilas P; Kyriakopoulou Z; Ruether IG; Dimitriou TG; Orfanoudakis G; Markoulatos P J Med Virol; 2015 Nov; 87(11):1973-80. PubMed ID: 25959607 [TBL] [Abstract][Full Text] [Related]
78. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation. Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730 [TBL] [Abstract][Full Text] [Related]
79. p63 drives invasion in keratinocytes expressing HPV16 E6/E7 genes through regulation of Src-FAK signalling. Srivastava K; Pickard A; McDade S; McCance DJ Oncotarget; 2017 Mar; 8(10):16202-16219. PubMed ID: 26001294 [TBL] [Abstract][Full Text] [Related]
80. Seroprevalence of 10 human papillomavirus types in the general rural population of Anyang, China: a cross-sectional study. Zhang C; Liu F; Deng Q; He Z; Xi L; Liu Y; Pan Y; Ning T; Guo C; Xu R; Zhang L; Cai H; Ke Y Sex Transm Infect; 2015 Nov; 91(7):506-9. PubMed ID: 25999521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]